A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Drostanolone
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Decitabine.
Drostanolone
Mycophenolic acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Decitabine.
Drostanolone
Busulfan
The risk or severity of adverse effects can be increased when Busulfan is combined with Decitabine.
Drostanolone
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Decitabine.
Drostanolone
Azacitidine
The risk or severity of adverse effects can be increased when Azacitidine is combined with Decitabine.
Drostanolone
Mechlorethamine
The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Decitabine.
Drostanolone
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Decitabine.
Chlorphenesin
Somapacitan
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Somapacitan.
Chlorphenesin
Satralizumab
The serum concentration of Sitagliptin can be decreased when it is combined with Satralizumab.
Chlorphenesin
Abametapir
The serum concentration of Sitagliptin can be increased when it is combined with Abametapir.
Chlorphenesin
Selpercatinib
The serum concentration of Sitagliptin can be increased when it is combined with Selpercatinib.
Chlorphenesin
Tucatinib
Sitagliptin may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Chlorphenesin
Thyroid, porcine
Thyroid, porcine may decrease the hypoglycemic activities of Sitagliptin.
Chlorphenesin
Tiratricol
Tiratricol may decrease the hypoglycemic activities of Sitagliptin.
Chlorphenesin
Liotrix
Liotrix may decrease the hypoglycemic activities of Sitagliptin.
Chlorphenesin
Cenobamate
The serum concentration of Sitagliptin can be decreased when it is combined with Cenobamate.
Chlorphenesin
Prednisolone acetate
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Sitagliptin.
Chlorphenesin
Betamethasone phosphate
The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Sitagliptin.
Chlorphenesin
Melengestrol acetate
The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Sitagliptin.
Chlorphenesin
Clocortolone acetate
The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Sitagliptin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3